Desjardins Global Asset Management Inc. Grows Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Desjardins Global Asset Management Inc. lifted its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 4.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 763 shares of the company’s stock after purchasing an additional 32 shares during the period. Desjardins Global Asset Management Inc.’s holdings in Molina Healthcare were worth $276,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of MOH. Raymond James Financial Services Advisors Inc. lifted its stake in shares of Molina Healthcare by 5.7% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,651 shares of the company’s stock valued at $551,000 after buying an additional 89 shares in the last quarter. Allianz Asset Management GmbH lifted its stake in shares of Molina Healthcare by 496.1% during the 1st quarter. Allianz Asset Management GmbH now owns 11,534 shares of the company’s stock valued at $3,848,000 after buying an additional 9,599 shares in the last quarter. Prudential PLC bought a new stake in Molina Healthcare in the 1st quarter valued at $422,000. Cetera Investment Advisers increased its holdings in Molina Healthcare by 10.1% in the 1st quarter. Cetera Investment Advisers now owns 1,296 shares of the company’s stock valued at $432,000 after acquiring an additional 119 shares during the last quarter. Finally, Mackay Shields LLC bought a new stake in Molina Healthcare in the 1st quarter valued at $2,814,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on MOH. Barclays began coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 price target on the stock. StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Wells Fargo & Company reduced their price target on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating on the stock in a report on Monday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a report on Thursday, April 4th. Finally, UBS Group lifted their price target on shares of Molina Healthcare from $350.00 to $380.00 and gave the company a “neutral” rating in a report on Thursday, December 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare presently has a consensus rating of “Hold” and an average price target of $393.09.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $360.84 on Friday. The company’s 50-day moving average price is $394.75 and its 200-day moving average price is $370.71. Molina Healthcare, Inc. has a twelve month low of $266.35 and a twelve month high of $423.92. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. The company has a market cap of $21.14 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, beating the consensus estimate of $4.31 by $0.07. The company had revenue of $9.05 billion for the quarter, compared to the consensus estimate of $8.35 billion. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The firm’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.10 EPS. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 23.62 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now directly owns 12,207 shares in the company, valued at approximately $4,688,220.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares in the company, valued at approximately $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares of the company’s stock, valued at $4,688,220.42. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,711 shares of company stock worth $6,472,517. Insiders own 1.10% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.